These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1630543)

  • 1. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of hemoglobin A1C in the management of diabetes in dialysis patients].
    Mácsai E; Rakk E; Miléder M; Fulcz A
    Orv Hetil; 2014 Sep; 155(36):1421-5. PubMed ID: 25176516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus.
    Yamanouchi T; Akanuma Y; Toyota T; Kuzuya T; Kawai T; Kawazu S; Yoshioka S; Kanazawa Y; Ohta M; Baba S
    Diabetes; 1991 Jan; 40(1):52-7. PubMed ID: 2015974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of fructosamine in hemodialysis patients].
    Küenburg E; Brunnbauer M; Watzinger U; Winter F; Müller MM; Graf H; Prager R
    Wien Klin Wochenschr Suppl; 1990; 180():11-3; discussion 32-3. PubMed ID: 2321384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients.
    Mittman N; Desiraju B; Fazil I; Kapupara H; Chattopadhyay J; Jani CM; Avram MM
    Kidney Int Suppl; 2010 Aug; (117):S41-5. PubMed ID: 20671744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?
    Ichikawa H; Nagake Y; Takahashi M; Nakazono H; Kawabata K; Shikata K; Makino H
    Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):305-8. PubMed ID: 8741392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in glycemic markers: a cross-sectional analysis of community-based data.
    Selvin E; Steffes MW; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL
    Ann Intern Med; 2011 Mar; 154(5):303-9. PubMed ID: 21357907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of fructosamine in chronic kidney diseases (dialysis-dependent patients)].
    Peheim E; Descoeudres C; Diem P; Colombo JP; Vorberg E
    Wien Klin Wochenschr Suppl; 1990; 180():13-20; discussion 32-3. PubMed ID: 2321385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.
    Rebholz CM; Grams ME; Chen Y; Gross AL; Sang Y; Coresh J; Selvin E
    Am J Epidemiol; 2017 Oct; 186(8):952-960. PubMed ID: 28535187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
    Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis.
    Nunoi K; Kodama T; Sato Y; Iwase M; Yoshizumi H; Kurimoto H; Nishitani H; Nakamura S; Fujishima M
    Metabolism; 1991 Sep; 40(9):986-9. PubMed ID: 1895965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.